Patent Assignment
Reel/Frame 059041/0818
Assignment of Assignor's Interest
Recorded: 2022-02-17
Pages: 10
Assignors
LIU, ZHIGANG
Executed: 2022-01-12
WAN, SHUNAN
Executed: 2022-01-12
LIU, YULAN
Executed: 2022-01-12
HAO, XIAOBO
Executed: 2022-01-12
HU, JUNJIE
Executed: 2022-01-12
GUO, JINGJING
Executed: 2022-01-12
Assignee
BEIJING WISDOMAB BIOTECHNOLOGY CO., LTD.
UNIT A-738, BUILDING NO.2, NO. 22 TONGJI NORTH ROAD, BEIJING ECONOMIC AND TECHNOLOGICAL DEVELOPMENT AREA, BEIJING, 101111, CHINA
Covered Property
(1)
Anti-CD3E/Bcma Bispecific Antibody and Use Thereof
Application:
17/620,290 →
Publication:
US 2023/0212287
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 17, 2022
From: BEIJING WISDOMAB BIOTECHNOLOGY CO., LTD.
To: BEIJING WISDOMAB BIOTECHNOLOGY CO., LTD.; GENRIX (SHANGHAI) BIOPHARMACEUTICAL CO., LTD.; CHONGQING GENRIX BIOPHARMACEUTICAL CO., LTD.
Reel/Frame 059041/0865 →
Assignment of Assignor's Interest
May 22, 2025
From: BEIJING WISDOMAB BIOTECHNOLOGY CO., LTD.; GENRIX (SHANGHAI) BIOPHARMACEUTICAL CO., LTD.
To: CHONGQING GENRIX BIOPHARMACEUTICAL CO., LTD.
Reel/Frame 071351/0777 →